NFKB1 and neoplasm: Targeting PGAM5 in tumor cells reduces mitochondrial DNA stress and suppresses M2 polarization via the TLR9/NF-κB/CCL2 axis, significantly improving the efficacy of immunotherapy in liver cancer (279).